US Health and Human Services Secretary Robert F. Kennedy Jr. attacks scientific literature with censorship to push MAHA ...
A transgender teen tested Roo, Planned Parenthood's AI-powered sexual health chatbot, which includes LGBTQ+ health topics, ...
The risk of cognitive outsourcing is real. But there is reason for optimism, if students are taught good AI habits early and ...
Morning Overview on MSN
An everyday ADHD pill is now being tested to slow early Alzheimer’s decline
Researchers enrolled 39 people with biomarker-confirmed mild cognitive impairment tied to Alzheimer’s disease in a phase II ...
There has been growing recognition that gut health may play a role in Parkinson’s disease—a brain disorder. This article ...
FDA’s draft “plausible mechanism” framework gives individualized genetic therapies a clearer path to market, but questions remain, write experts at Morrison Foerster.
Morning Overview on MSN
An experimental drug doubled one-year survival for pancreatic cancer patients
Patients with metastatic pancreatic cancer who received the experimental drug elraglusib alongside standard chemotherapy saw ...
Scaling effective solutions often stalls in state government because funding systems are not designed to reward proof of ...
Previous research has associated the live-attenuated shingles vaccine to a lower risk of developing dementia. Now, an ...
Results from the Phase 3 VELA clinical trials at Week 52 in adults with moderate-to-severe hidradenitis suppurativa (HS) demonstrate ...
Nothing about long Covid adds up. All of this is very strange. Stranger still are patients’ stories of astonishing recoveries ...
Part C domestic enrollment is underway at three clinical sites in the U.S.CHICAGO, June 25, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results